13th Edition of International Conference on Neurology and Brain Disorders
October 19-21, 2026
Acetylcholine
Acetylcholine (ACh) is an organic chemical compound found naturally in the body that acts as a neurotransmitter in the brain, spinal cord, and musculoskeletal system. It is responsible for controlling a wide range of motor and autonomic functions. These include the regulation of heart rate, breathing, muscle contractions, and digestion, as well as memory, learning, and sleep. ACh is also involved in coordinating responses to stimuli and in the transmission of pain signals throughout the body. Acetylcholine is produced in two primary types of cells located in the brain and throughout the nervous system: cholinergic neurons and non-neuronal cells. Release of ACh from the cholinergic neurons is regulated by two interacting pathways: the cholinergic presynaptic and the non-cholinergic postsynaptic. The presynaptic pathways involve the release of ACh from cholinergic neurons, whereas the postsynaptic pathways involve the binding of ACh to the postsynaptic neurons or receptors. ACh acts as a chemical messenger between neurons and other cells in the body, and is essential for proper communication between these structures. ACh binds to two major types of receptors: nicotinic and muscarinic. Nicotinic receptors are located in the synapses between neurons, and are responsible for creating rapid, excitatory responses in the neurons they connect. Muscarinic receptors are found on postsynaptic neurons, and typically cause slower, inhibitory responses.
Ken Ware
NeuroPhysics Therapy Institute and Research Centre, Australia
Yong Xiao Wang
Albany Medical College, United States
Joe Sam Robinson
Mercer University, United States
Daniel Curry
Texas Children’s Hospital, United States
Steven Benvenisti
Davis, Saperstein Salomon, PC, United States
Andrzej Stanislaw Cieplak
Independent researcher, United States
Younok Dumortier Shin
OnusBio, United StatesSubmit your abstract Today
Title : Atypical presentation of Juvenile myoclonic epilepsy in a 16-year-old female: A case report
George Diaz, Memorial Healthcare Systems, United States
Title : Triple-network dysfunction, ME/CFS, and the NeuroPhysics Treatment Process “A dynamical systems perspective on psychophysical organization and environmental interaction”
Ken Ware, NeuroPhysics Therapy Institute and Research Centre, Australia
Title : Beyond plaques: 10-nanometer-scale pathoconnectomics of Alzheimer’s disease
Ons M Saad, Panluminate Inc., United States
Title : Results from the global phase 3 trial (IB1001-303) evaluating levacetylleucine in children and adults with ataxia-telangiectasia
Chidinma Ejim, IntraBio, United States
Title : A phase 3, multinational, randomized, placebo-controlled, double-blind, crossover trial (IB1001-304) evaluating levacetylleucine in CACNA1A
Chidinma Ejim, IntraBio, United States
Title : Clinical and molecular phenotype of PTRHD1-associated juvenile parkinsonism
Bhavan A Modi, Barrow Neurological Institute at Phoenix Children's, United States